The University of Chicago Header Logo

Gladell P. Paner

Concepts (467)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
35
2024
383
9.630
Why?
Carcinoma, Transitional Cell
18
2023
164
5.430
Why?
Prostatic Neoplasms
48
2024
1721
4.730
Why?
Kidney Neoplasms
29
2024
621
4.250
Why?
Carcinoma, Renal Cell
20
2024
426
3.780
Why?
Neoplasm Staging
31
2021
1939
3.510
Why?
Adenocarcinoma
23
2024
1169
3.440
Why?
Biomarkers, Tumor
33
2024
1464
3.340
Why?
Urologic Neoplasms
9
2021
77
3.280
Why?
Urothelium
15
2022
70
3.010
Why?
Urinary Bladder
12
2024
246
2.970
Why?
Neoplasm Grading
30
2023
357
2.690
Why?
Carcinoma
15
2020
436
2.640
Why?
Carcinoma in Situ
4
2023
53
1.890
Why?
Immunohistochemistry
27
2020
1753
1.610
Why?
Pathology, Clinical
6
2021
33
1.560
Why?
Prostate
16
2024
378
1.540
Why?
Cystadenoma
3
2021
19
1.420
Why?
Humans
142
2024
86678
1.320
Why?
Pathologists
5
2023
24
1.310
Why?
Urology
4
2023
110
1.160
Why?
Male
91
2024
40988
1.160
Why?
Neoplasm Invasiveness
13
2020
552
1.100
Why?
Prostatectomy
13
2022
471
0.980
Why?
Carcinoma, Squamous Cell
4
2023
1077
0.970
Why?
Urogenital Neoplasms
1
2024
23
0.970
Why?
Lymphatic Metastasis
6
2020
486
0.930
Why?
Prognosis
24
2022
3680
0.920
Why?
Neoplasms, Complex and Mixed
2
2014
7
0.900
Why?
Carcinoma, Ductal
6
2020
18
0.850
Why?
Carcinoma, Papillary
5
2021
158
0.830
Why?
Diagnosis, Differential
16
2024
1566
0.830
Why?
Seminal Vesicles
2
2021
39
0.820
Why?
Aged
45
2021
18423
0.820
Why?
Meningeal Neoplasms
1
2021
61
0.800
Why?
Meningioma
1
2021
60
0.800
Why?
Wolffian Ducts
1
2021
7
0.800
Why?
Disease Management
2
2020
327
0.800
Why?
Testicular Neoplasms
2
2014
105
0.800
Why?
Urethral Neoplasms
1
2021
10
0.790
Why?
Muscle Proteins
3
2011
132
0.760
Why?
Precancerous Conditions
1
2022
196
0.760
Why?
Cytoskeletal Proteins
3
2011
223
0.740
Why?
Neoplasm Recurrence, Local
6
2020
1313
0.730
Why?
Diverticulum
3
2017
44
0.730
Why?
Predictive Value of Tests
16
2020
1673
0.710
Why?
Neoplasm Proteins
5
2020
532
0.670
Why?
Neoplasms, Cystic, Mucinous, and Serous
2
2018
16
0.660
Why?
Middle Aged
48
2021
25040
0.630
Why?
Antibodies
3
2012
350
0.630
Why?
Venous Thromboembolism
1
2020
153
0.630
Why?
Biopsy
15
2020
1163
0.610
Why?
Hemangiosarcoma
2
2014
17
0.600
Why?
Models, Statistical
2
2020
575
0.590
Why?
Muscle, Smooth
2
2009
354
0.580
Why?
Cystadenocarcinoma
1
2016
12
0.580
Why?
Prostate-Specific Antigen
9
2023
353
0.560
Why?
Aged, 80 and over
19
2019
6513
0.550
Why?
Female
41
2021
44550
0.490
Why?
Mucous Membrane
3
2011
83
0.490
Why?
Choriocarcinoma, Non-gestational
1
2014
1
0.490
Why?
Biopsy, Needle
4
2015
235
0.480
Why?
Gastrointestinal Neoplasms
3
2003
106
0.480
Why?
Cell Nucleus
5
2010
580
0.430
Why?
In Situ Hybridization, Fluorescence
2
2018
348
0.420
Why?
Carcinoma, Neuroendocrine
1
2012
28
0.420
Why?
Rete Testis
1
2011
1
0.400
Why?
Carcinoma, Embryonal
1
2011
2
0.400
Why?
Leydig Cells
1
2011
11
0.400
Why?
Epididymitis
1
2011
5
0.400
Why?
Pluripotent Stem Cells
1
2011
31
0.390
Why?
Ureteral Neoplasms
3
2017
13
0.390
Why?
Reproducibility of Results
7
2023
2706
0.380
Why?
Neoplasms, Germ Cell and Embryonal
1
2011
47
0.380
Why?
Genital Neoplasms, Male
2
2021
11
0.380
Why?
Adenoma, Oxyphilic
3
2007
28
0.370
Why?
Disease Progression
5
2018
1532
0.370
Why?
Adenocarcinoma, Mucinous
3
2009
48
0.370
Why?
Adult
29
2018
25659
0.370
Why?
Lymph Nodes
3
2016
533
0.360
Why?
Observer Variation
5
2015
603
0.350
Why?
Homeodomain Proteins
5
2024
536
0.340
Why?
Terminology as Topic
4
2021
217
0.340
Why?
Rhabdomyosarcoma, Alveolar
1
2008
4
0.330
Why?
Risk Assessment
5
2020
2264
0.330
Why?
SOXB1 Transcription Factors
2
2022
21
0.320
Why?
Cysts
2
2014
104
0.320
Why?
Specialization
2
2020
65
0.310
Why?
Carcinoma, Small Cell
1
2008
134
0.310
Why?
Cystectomy
3
2020
102
0.300
Why?
Carcinoma, Acinar Cell
2
2017
11
0.290
Why?
Chromosomes, Human, Pair 1
1
2007
100
0.290
Why?
Kidney Tubules, Collecting
2
2018
23
0.280
Why?
Hyperplasia
2
2022
148
0.280
Why?
Mexico
2
2018
67
0.280
Why?
Kidney Medulla
2
2018
80
0.270
Why?
Neoplasm Seeding
1
2005
16
0.270
Why?
Cell Differentiation
6
2016
1458
0.270
Why?
Stromal Cells
2
2003
143
0.260
Why?
Giant Cells
1
2005
19
0.260
Why?
Chromosome Aberrations
1
2007
387
0.260
Why?
Osteoclasts
1
2005
33
0.260
Why?
Retroperitoneal Space
1
2005
38
0.260
Why?
Rhabdomyosarcoma
1
2005
40
0.260
Why?
Statistics as Topic
1
2006
238
0.260
Why?
Ploidies
3
2018
40
0.250
Why?
Antigens, Neoplasm
3
2020
325
0.250
Why?
Neoplasm Metastasis
6
2018
1056
0.250
Why?
Transcription Factors
6
2024
1565
0.240
Why?
Soft Tissue Neoplasms
1
2005
127
0.240
Why?
Kidney
3
2022
1242
0.240
Why?
Receptors, Androgen
2
2016
113
0.240
Why?
Graves Disease
1
2004
36
0.240
Why?
Pleural Effusion, Malignant
1
2003
15
0.230
Why?
Adenoma
1
2005
237
0.230
Why?
Urinary Bladder Diseases
2
2015
41
0.230
Why?
Cerebellopontine Angle
1
2003
7
0.230
Why?
Neoplasms, Fibrous Tissue
1
2002
2
0.220
Why?
Cerebellar Neoplasms
1
2003
36
0.220
Why?
Quadriplegia
1
2002
22
0.220
Why?
Lymphoma, B-Cell
1
2003
103
0.220
Why?
Cytogenetic Analysis
4
2007
71
0.220
Why?
Practice Patterns, Physicians'
2
2020
584
0.220
Why?
Fallopian Tube Neoplasms
1
2002
35
0.210
Why?
Tissue Array Analysis
5
2018
124
0.210
Why?
Hepacivirus
1
2003
160
0.210
Why?
Spinal Cord Neoplasms
1
2002
48
0.210
Why?
Hemangioendothelioma, Epithelioid
1
2002
9
0.210
Why?
Chemotherapy, Adjuvant
2
2021
468
0.210
Why?
Time Factors
3
2018
5214
0.210
Why?
Sensitivity and Specificity
6
2021
1992
0.210
Why?
Public Health
1
2023
129
0.210
Why?
Neurofibromin 2
1
2021
30
0.210
Why?
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
1
2021
54
0.200
Why?
Ki-67 Antigen
2
2020
64
0.200
Why?
Lymph Node Excision
2
2016
217
0.200
Why?
Pleural Neoplasms
1
2003
188
0.200
Why?
Neoadjuvant Therapy
2
2021
318
0.200
Why?
Esophageal Neoplasms
1
2024
322
0.200
Why?
Clinical Decision-Making
2
2020
257
0.200
Why?
Liver Cirrhosis
1
2003
300
0.200
Why?
Hepatitis C
1
2003
210
0.190
Why?
Translocation, Genetic
1
2021
265
0.190
Why?
Myeloid Ecotropic Viral Integration Site 1 Protein
2
2018
20
0.190
Why?
Kallikreins
1
2020
47
0.190
Why?
Databases, Factual
3
2020
816
0.190
Why?
Artificial Intelligence
1
2023
298
0.190
Why?
Trans-Activators
1
2003
429
0.190
Why?
Incidental Findings
2
2019
95
0.180
Why?
Biopsy, Large-Core Needle
2
2020
14
0.180
Why?
Muscles
1
2020
194
0.180
Why?
Necrosis
1
2020
204
0.180
Why?
Neoplasms, Glandular and Epithelial
3
2009
74
0.180
Why?
Disease Susceptibility
1
2020
193
0.180
Why?
Urologic Surgical Procedures
1
2021
146
0.180
Why?
Health Resources
1
2020
76
0.170
Why?
Urachus
1
2019
2
0.170
Why?
Retrospective Studies
12
2021
8496
0.170
Why?
DNA Methylation
1
2024
628
0.170
Why?
Molecular Targeted Therapy
2
2019
266
0.170
Why?
Cell Death
1
2020
256
0.170
Why?
Databases, Genetic
1
2020
260
0.170
Why?
Diffusion Magnetic Resonance Imaging
1
2021
294
0.170
Why?
Thyroid Neoplasms
1
2004
408
0.170
Why?
beta Catenin
2
2017
251
0.170
Why?
High-Throughput Nucleotide Sequencing
2
2019
456
0.170
Why?
United States
7
2021
6681
0.170
Why?
Cell Proliferation
3
2020
1579
0.170
Why?
Phenylthiohydantoin
2
2016
41
0.170
Why?
DNA-Binding Proteins
2
2012
1208
0.160
Why?
Neoplasms, Multiple Primary
2
2017
100
0.160
Why?
Fumarate Hydratase
1
2018
6
0.160
Why?
Gene Expression Regulation, Neoplastic
5
2018
1197
0.160
Why?
Phenotype
3
2020
2380
0.160
Why?
Pancreatic Neoplasms
2
2001
645
0.160
Why?
Treatment Outcome
3
2021
7998
0.160
Why?
Prostatic Neoplasms, Castration-Resistant
2
2017
111
0.160
Why?
Fatal Outcome
4
2009
295
0.150
Why?
Gene Expression
2
2020
1284
0.150
Why?
Acinar Cells
1
2017
6
0.150
Why?
Uroplakin III
2
2014
3
0.150
Why?
Early Detection of Cancer
1
2021
395
0.150
Why?
Mutation
5
2019
3968
0.150
Why?
PTEN Phosphohydrolase
1
2017
128
0.150
Why?
GATA3 Transcription Factor
2
2013
48
0.150
Why?
Mullerian Ducts
1
2016
17
0.150
Why?
Cystadenocarcinoma, Papillary
1
2016
9
0.140
Why?
Iatrogenic Disease
1
2017
69
0.140
Why?
Liver
1
2002
1230
0.140
Why?
Young Adult
6
2018
5980
0.140
Why?
Neoplastic Cells, Circulating
1
2017
70
0.140
Why?
Neuroendocrine Tumors
1
2018
105
0.140
Why?
Incidence
5
2017
1578
0.140
Why?
Consensus
4
2021
336
0.140
Why?
Organogenesis
1
2016
41
0.140
Why?
Urologic Diseases
1
2017
45
0.140
Why?
Ureter
1
2017
92
0.140
Why?
Liver Neoplasms
2
2002
738
0.140
Why?
Precision Medicine
1
2020
395
0.140
Why?
Mesoderm
1
2016
108
0.140
Why?
Signal Transduction
6
2018
3243
0.140
Why?
Immunotherapy
1
2021
629
0.140
Why?
Karyotyping
2
2007
250
0.140
Why?
Carcinoma, Hepatocellular
1
2000
386
0.130
Why?
Logistic Models
4
2023
1188
0.130
Why?
Survival Rate
4
2015
1864
0.130
Why?
Neoplasms
2
2021
2898
0.130
Why?
Xanthomatosis
1
2015
5
0.130
Why?
Algorithms
1
2023
1830
0.130
Why?
Drug Resistance, Neoplasm
2
2016
592
0.130
Why?
Benzamides
4
2016
229
0.120
Why?
Uroplakin II
1
2014
1
0.120
Why?
Genetic Predisposition to Disease
2
2020
2271
0.120
Why?
Survival Analysis
2
2016
1538
0.120
Why?
Antineoplastic Agents
4
2018
2360
0.120
Why?
Gene Expression Profiling
5
2016
1384
0.120
Why?
Population Surveillance
1
2015
219
0.120
Why?
World Health Organization
3
2008
103
0.110
Why?
Combined Modality Therapy
2
2008
1686
0.110
Why?
Orchiectomy
1
2013
68
0.110
Why?
Tumor Microenvironment
1
2016
418
0.110
Why?
Prostatic Intraepithelial Neoplasia
1
2012
21
0.110
Why?
Tumor Burden
1
2014
289
0.110
Why?
Pathology, Molecular
1
2012
34
0.110
Why?
Pelvic Neoplasms
1
2012
45
0.110
Why?
Hyaluronan Receptors
2
2012
36
0.110
Why?
Protein Interaction Maps
1
2012
48
0.110
Why?
Neoplasms, Radiation-Induced
1
2012
109
0.110
Why?
Thymus Gland
1
2013
195
0.100
Why?
Sarcoma
2
2005
215
0.100
Why?
Risk Factors
3
2018
5420
0.100
Why?
T-Lymphocytes
2
2016
1195
0.100
Why?
CDX2 Transcription Factor
1
2011
7
0.100
Why?
Kidney Pelvis
2
2009
50
0.100
Why?
Adrenogenital Syndrome
1
2011
1
0.100
Why?
17-Ketosteroids
1
2011
13
0.100
Why?
Tropism
1
2011
4
0.100
Why?
Proto-Oncogene Proteins c-fyn
1
2011
24
0.100
Why?
Receptors, Growth Factor
1
2011
52
0.100
Why?
Enzyme Inhibitors
2
2005
639
0.100
Why?
Piperazines
2
2003
272
0.100
Why?
Papilloma
1
2011
22
0.100
Why?
Cell Shape
1
2011
51
0.100
Why?
Hepatocyte Growth Factor
1
2011
84
0.090
Why?
Hemangioma, Capillary
1
2010
7
0.090
Why?
Vascular Neoplasms
1
2010
19
0.090
Why?
Immune Tolerance
1
2013
337
0.090
Why?
Image Cytometry
2
2007
12
0.090
Why?
T-Lymphocytes, Regulatory
1
2013
295
0.090
Why?
Arteriovenous Malformations
1
2010
41
0.090
Why?
Pyrimidines
2
2003
370
0.090
Why?
DNA, Neoplasm
4
2018
265
0.090
Why?
Pseudomyxoma Peritonei
1
2009
3
0.090
Why?
Repressor Proteins
1
2013
403
0.090
Why?
Adolescent
4
2018
8984
0.090
Why?
Megakaryocyte Progenitor Cells
1
2009
1
0.090
Why?
Thrombopoiesis
1
2009
4
0.090
Why?
PAX2 Transcription Factor
1
2009
6
0.090
Why?
Proto-Oncogene Proteins c-met
1
2011
199
0.090
Why?
Erythroid Precursor Cells
1
2009
32
0.090
Why?
Pelvis
1
2009
95
0.090
Why?
Carbonic Anhydrases
1
2009
15
0.080
Why?
Histiocytosis, Sinus
1
2008
14
0.080
Why?
Kidney Failure, Chronic
1
2014
509
0.080
Why?
Antibody Specificity
1
2009
129
0.080
Why?
Anaplasia
1
2008
5
0.080
Why?
Desmin
1
2008
10
0.080
Why?
Myogenin
1
2008
5
0.080
Why?
Synaptophysin
1
2008
11
0.080
Why?
Pancreatic Diseases
1
2008
52
0.080
Why?
MyoD Protein
1
2008
15
0.080
Why?
Adenocarcinoma, Follicular
1
2009
51
0.080
Why?
Transcriptome
1
2013
580
0.080
Why?
Proto-Oncogene Proteins c-myc
1
2009
120
0.080
Why?
Environmental Exposure
1
2011
296
0.080
Why?
MicroRNAs
1
2013
534
0.080
Why?
Peritoneal Neoplasms
1
2009
177
0.080
Why?
Aneuploidy
1
2007
55
0.080
Why?
Antibodies, Monoclonal
1
2014
1376
0.080
Why?
Societies, Scientific
1
2007
44
0.070
Why?
Cadherins
1
2007
151
0.070
Why?
Colonic Neoplasms
1
2011
558
0.070
Why?
Epigenesis, Genetic
1
2011
481
0.070
Why?
Imatinib Mesylate
2
2003
126
0.070
Why?
Robotics
1
2009
267
0.070
Why?
Chromosome Deletion
1
2007
229
0.070
Why?
Wilms Tumor
1
2005
38
0.070
Why?
Radiotherapy
2
2018
328
0.070
Why?
Magnetic Resonance Imaging
3
2021
3362
0.070
Why?
Cohort Studies
4
2017
2768
0.060
Why?
Cell Division
2
2004
696
0.060
Why?
Sphingosine
1
2005
71
0.060
Why?
Nephrons
1
2004
18
0.060
Why?
Sentinel Lymph Node Biopsy
1
2005
68
0.060
Why?
Chicago
2
2021
1380
0.060
Why?
Practice Guidelines as Topic
2
2012
1037
0.060
Why?
Biomarkers
1
2011
1718
0.060
Why?
Genetic Variation
2
2024
1351
0.060
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2005
136
0.060
Why?
Nitriles
2
2016
149
0.060
Why?
Protein Kinase C
1
2005
270
0.060
Why?
Thyrotoxicosis
1
2004
18
0.060
Why?
Disease-Free Survival
3
2015
1204
0.060
Why?
Herpesvirus 8, Human
1
2003
11
0.060
Why?
HIV Seronegativity
1
2003
12
0.060
Why?
Herpesviridae Infections
1
2003
46
0.060
Why?
Carcinoma, Lobular
1
2004
81
0.060
Why?
ROC Curve
2
2021
752
0.060
Why?
Tyrphostins
1
2003
7
0.060
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2004
113
0.060
Why?
Cell Line, Tumor
3
2016
2426
0.060
Why?
Urologists
1
2023
24
0.060
Why?
Immunophenotyping
1
2003
211
0.060
Why?
Prospective Studies
2
2021
4214
0.060
Why?
STAT3 Transcription Factor
1
2003
78
0.060
Why?
Thyroidectomy
1
2004
170
0.060
Why?
HIV-1
1
2003
163
0.050
Why?
Carcinosarcoma
1
2002
20
0.050
Why?
National Institutes of Health (U.S.)
1
2003
122
0.050
Why?
Embolization, Therapeutic
1
2005
238
0.050
Why?
Xenograft Model Antitumor Assays
2
2016
458
0.050
Why?
Genetic Markers
2
2018
476
0.050
Why?
Immunoenzyme Techniques
3
2007
303
0.050
Why?
Neovascularization, Pathologic
1
2004
353
0.050
Why?
Perception
1
2023
168
0.050
Why?
Proto-Oncogene Proteins c-bcl-2
1
2003
189
0.050
Why?
Laparotomy
1
2002
59
0.050
Why?
Mice
5
2016
11356
0.050
Why?
Review Literature as Topic
1
2021
21
0.050
Why?
Breast Neoplasms
2
2005
2903
0.050
Why?
Carcinoma, Islet Cell
1
2000
3
0.050
Why?
Phosphorylation
1
2003
1106
0.050
Why?
Bile
1
2000
57
0.050
Why?
Apoptosis
2
2005
1683
0.050
Why?
Carcinoma, Large Cell
1
2000
39
0.050
Why?
Mice, Nude
2
2013
790
0.050
Why?
Communication
1
2023
442
0.040
Why?
Animals
6
2016
26590
0.040
Why?
Patient Care
1
2021
100
0.040
Why?
Microscopy, Electron
1
2000
503
0.040
Why?
Health Care Surveys
1
2020
278
0.040
Why?
International Cooperation
1
2019
127
0.040
Why?
Pregnancy
1
2005
2894
0.040
Why?
Epithelial Cells
2
2013
669
0.040
Why?
Urinary Diversion
1
2018
42
0.040
Why?
Brazil
1
2018
69
0.040
Why?
Australia
1
2018
99
0.040
Why?
Canada
1
2018
204
0.040
Why?
Electronic Health Records
1
2021
320
0.040
Why?
Europe
1
2018
309
0.040
Why?
Human Embryonic Stem Cells
1
2016
5
0.040
Why?
Retinoblastoma Protein
1
2017
66
0.040
Why?
Neoplasms, Second Primary
2
2009
252
0.040
Why?
Androgen Receptor Antagonists
1
2016
18
0.040
Why?
Receptor, Fibroblast Growth Factor, Type 3
1
2016
23
0.040
Why?
DNA Mutational Analysis
1
2018
526
0.040
Why?
Genome-Wide Association Study
1
2024
1621
0.040
Why?
Immunomodulation
1
2016
55
0.030
Why?
SEER Program
1
2016
190
0.030
Why?
PPAR gamma
1
2016
66
0.030
Why?
Urethra
1
2016
113
0.030
Why?
Epithelium
1
2016
319
0.030
Why?
Polymorphism, Single Nucleotide
1
2024
2357
0.030
Why?
Salvage Therapy
1
2016
233
0.030
Why?
Cell Lineage
1
2016
273
0.030
Why?
Cluster Analysis
1
2016
369
0.030
Why?
Lymphocytes, Tumor-Infiltrating
1
2016
123
0.030
Why?
HIV Infections
1
2003
772
0.030
Why?
Programmed Cell Death 1 Receptor
1
2016
159
0.030
Why?
Oligonucleotide Array Sequence Analysis
2
2009
689
0.030
Why?
Kaplan-Meier Estimate
1
2017
861
0.030
Why?
Hyperlipidemias
1
2015
95
0.030
Why?
Sequence Analysis, DNA
1
2018
853
0.030
Why?
Protein Binding
1
2018
1457
0.030
Why?
B7-H1 Antigen
1
2016
250
0.030
Why?
Hypercholesterolemia
1
2015
161
0.030
Why?
Infant
2
2011
3047
0.030
Why?
Gene Regulatory Networks
1
2016
296
0.030
Why?
Antigens, Polyomavirus Transforming
1
2013
47
0.030
Why?
Keratin-20
1
2012
6
0.030
Why?
CD4 Antigens
1
2013
83
0.030
Why?
Keratin-14
1
2012
5
0.030
Why?
Desmoglein 3
1
2012
5
0.030
Why?
Child
2
2018
6928
0.030
Why?
Pre-B-Cell Leukemia Transcription Factor 1
1
2012
5
0.030
Why?
Embryonic Stem Cells
1
2013
78
0.030
Why?
Decision Trees
1
2012
63
0.030
Why?
Preoperative Period
1
2012
91
0.030
Why?
Illinois
1
2013
462
0.030
Why?
Autoantigens
1
2013
127
0.030
Why?
Calcium-Binding Proteins
1
2012
115
0.030
Why?
Forkhead Transcription Factors
1
2013
166
0.030
Why?
Protein Interaction Mapping
1
2012
82
0.030
Why?
Androgen Antagonists
1
2013
144
0.030
Why?
Cell Line
1
2016
2469
0.030
Why?
Interdisciplinary Communication
1
2012
130
0.030
Why?
Cooperative Behavior
1
2012
175
0.020
Why?
Tumor Suppressor Proteins
1
2013
279
0.020
Why?
Tumor Suppressor Protein p53
1
2012
381
0.020
Why?
Mice, Inbred C57BL
1
2016
3095
0.020
Why?
Mucins
1
2009
39
0.020
Why?
Thrombocytosis
1
2009
8
0.020
Why?
Follow-Up Studies
1
2016
3642
0.020
Why?
Granulocytes
1
2009
37
0.020
Why?
Models, Biological
1
2016
1749
0.020
Why?
Megakaryocytes
1
2009
36
0.020
Why?
Carbonic Anhydrase IX
1
2009
11
0.020
Why?
Cell Size
1
2009
65
0.020
Why?
Recurrence
1
2012
1139
0.020
Why?
Leukopenia
1
2009
65
0.020
Why?
Mice, Transgenic
1
2013
1540
0.020
Why?
RNA, Small Interfering
1
2011
547
0.020
Why?
Jaundice, Obstructive
1
2008
10
0.020
Why?
Histiocytes
1
2008
22
0.020
Why?
Antigens, Differentiation, Myelomonocytic
1
2008
32
0.020
Why?
Microscopy, Electron, Transmission
1
2009
134
0.020
Why?
Demography
1
2009
177
0.020
Why?
S100 Proteins
1
2008
50
0.020
Why?
Blood Platelets
1
2009
149
0.020
Why?
Proto-Oncogene Proteins
1
2012
645
0.020
Why?
Thoracic Surgery, Video-Assisted
1
2008
30
0.020
Why?
Erythrocytes
1
2009
255
0.020
Why?
Anemia
1
2009
128
0.020
Why?
Adenocarcinoma, Papillary
1
2007
8
0.020
Why?
Fluorescent Antibody Technique, Indirect
1
2007
68
0.020
Why?
Carcinoma, Medullary
1
2007
11
0.020
Why?
Discriminant Analysis
1
2007
66
0.020
Why?
Bone Marrow
1
2009
435
0.020
Why?
Cell Movement
1
2011
758
0.020
Why?
Regression Analysis
1
2008
596
0.020
Why?
Adenocarcinoma, Clear Cell
1
2007
62
0.020
Why?
Eosinophilia
1
2007
84
0.020
Why?
Nephrectomy
1
2009
294
0.020
Why?
RNA, Messenger
1
2013
1981
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
879
0.020
Why?
Antigens, CD
1
2008
458
0.020
Why?
Photometry
1
2006
14
0.020
Why?
Macrophages
1
2009
557
0.020
Why?
Co-Repressor Proteins
1
2005
18
0.020
Why?
Cyclic AMP Response Element-Binding Protein
1
2005
66
0.020
Why?
Clavicle
1
2004
11
0.020
Why?
Paraffin Embedding
1
2005
78
0.020
Why?
Sex Distribution
1
2005
173
0.020
Why?
Mitotic Index
1
2004
20
0.020
Why?
Molecular Chaperones
1
2005
111
0.020
Why?
Frozen Sections
1
2005
48
0.020
Why?
Age Distribution
1
2005
204
0.020
Why?
Axilla
1
2005
99
0.020
Why?
Isoenzymes
1
2005
271
0.020
Why?
Mice, Knockout
1
2009
1924
0.020
Why?
B-Lymphocytes
1
2009
724
0.020
Why?
Staining and Labeling
1
2004
165
0.010
Why?
Down-Regulation
1
2005
506
0.010
Why?
Blotting, Western
1
2005
782
0.010
Why?
Adaptor Proteins, Signal Transducing
1
2005
302
0.010
Why?
Intracellular Signaling Peptides and Proteins
1
2005
379
0.010
Why?
Cell Survival
1
2005
969
0.010
Why?
Proto-Oncogene Proteins c-kit
1
2002
79
0.010
Why?
Periodic Acid-Schiff Reaction
1
2001
6
0.010
Why?
Lymphangioma
1
2001
15
0.010
Why?
Bone Neoplasms
1
2004
322
0.010
Why?
Child, Preschool
1
2008
3613
0.010
Why?
Cystadenocarcinoma, Serous
1
2001
45
0.010
Why?
Carrier Proteins
1
2005
673
0.010
Why?
Nuclear Proteins
1
2005
696
0.010
Why?
Image Processing, Computer-Assisted
1
2006
1204
0.010
Why?
Postoperative Complications
1
2009
2207
0.010
Why?
Paner's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (467)
Explore
_
Co-Authors (29)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_